AlphaYouST
Insider selling
Seshu Tyagarajan sold $84K of Candel Therapeutics, Inc. (CADL) stock
Seshu Tyagarajan, Chief Technology Officer of Candel Therapeutics, Inc. (CADL), sold 7,000 shares of CADL stock worth $84K, per an SEC Form 4 filed Aug 19, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Aug 17, 2026, 2 days before it was made public.
CADL has moved -10.8% since the trade date, from $12.16 to $10.85 (Sep 18, 2026 close).
- Traded
- Aug 17, 2026
- Disclosed
- Aug 19, 2026
- Filing delay
- 2 days
- Price since
- -10.8%
- Role
- Chief Technology Officer
- Source
- SEC Form 4
More CADL insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.